Celularity (CELU) Receivables (2020 - 2025)

Celularity (CELU) has reported Receivables for 6 consecutive years, with $4.7 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Receivables fell 65.68% year-over-year to $4.7 million in Q4 2025; TTM through Dec 2025 was $4.7 million, a 65.68% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 65.68% from the prior year.
• Receivables was $4.7 million for Q4 2025 at Celularity, down from $6.7 million in the prior quarter.
• Over five years, Receivables peaked at $15.8 million in Q1 2024 and troughed at $4.7 million in Q4 2025.
• A 5-year average of $8.8 million and a median of $7.0 million in 2021 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 206.7% in 2024 and slumped 65.68% in 2025, its largest moves.
• Over 5 years, Receivables stood at $5.2 million in 2021, then jumped by 33.12% to $7.0 million in 2022, then soared by 73.96% to $12.1 million in 2023, then rose by 11.87% to $13.6 million in 2024, then tumbled by 65.68% to $4.7 million in 2025.
• The last three Receivables figures came in at $4.7 million (Q4 2025), $6.7 million (Q3 2025), and $11.2 million (Q2 2025), per Business Quant data.